Morphological and functional in vitro and in vivo characterization of the mouse corpus cavernosum

British Journal of Pharmacology

Volumn 132, Issue 6, 2001, Pages 1333-1341

  Mizusawa, Hiroya ^a   Hedlund, Petter ^a   Håkansson, Anders ^a   Alm, Per ^a   Andersson, Karl Erik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cholinergic; Cyclic GMP; In vivo; Mouse; Nerves; Nitric oxide; Penile erection; Peptides; Relaxation; Sildenafil

Indexed keywords

ADENYLATE CYCLASE; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; CYCLIC GMP; FORSKOLIN; N(G) NITROARGININE METHYL ESTER; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; NORADRENALIN; PRAZOSIN; SCOPOLAMINE; SILDENAFIL; TYROSINE 3 MONOOXYGENASE; VASOACTIVE INTESTINAL POLYPEPTIDE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL SYMPATHECTOMY; CHOLINERGIC SYSTEM; CORPUS CAVERNOSUM; ENDOTHELIUM CELL; IMMUNOREACTIVITY; MALE; MOUSE; NERVE EXCITABILITY; NERVE STIMULATION; NONHUMAN; PENIS ERECTION; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER;

EID: 0035076527     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703938     Document Type: Article

References (29)

1. The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat
2. Physiology of penile erection
3. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
4. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase
5. Physiological aging and penile erectile function: A study in the rat
6. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog
7. Neural and endothelial nitric oxide synthase activity in rat penile erectile tissue
8. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
9. Antierectile role of the sympathetic nervous system in rats
10. A possible role for S-nitrosothiols at the nitrergic relaxations in the mouse CC
11. An in vitro study of nonadrenergic-noncholinergic activity on the cavernous tissue of mouse
12. NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum
13. Pre- and postjunctional adreno- and muscarinic receptor functions in the isolated human corpus spongiosum urethrae
14. Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice
15. Distribution and function of nitric oxide containing nerves in canine corpus cavernosum and spongiosum
16. Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase
17. Characterisation of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man
18. Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit
19. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
20. Neurophysiological aspects of penile erection: The role of the sympathetic nervous system
21. A possible neural source of nitric oxide in the rat penis
22. Neuropeptide Y (NPY) in human penile corpus cavernosum tissue and circumflex veins - Occurrence and in vitro effects
23. Intracellular cyclic GMP receptor proteins
24. Hemodynamics of erection in the monkey
25. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide
26. Rat model for the study of penile erection: Pharmacologic and electrical-stimulation parameters
27. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
28. A large proportion of pelvic neurons innervating the corpora cavernosa of the rat penis exhibit NADPH-diaphorase activity
29. Intracavernosal pressure monitoring in mice: Responses to electrical field stimulation of the cavernous nerve and to intracavernousal drug administration